Psychedelic Business Spotlight: June 18, 2021
This week in psychedelic business news: Patent progress for biosynthetic psilocybin, psychedelics for brain health, and psychedelic and cannabis companies team up in the name of research.
Entries by Jennifer Walker-Journey
Extended-Release Ketamine Effective in Patients With Treatment-Resistant Depression
Ketamine may offer new hope for sufferers of treatment resistant depression via an extended-release oral administered option.
Bringing Next-Gen Depression Treatment to Market: PharmaTher’s Ketamine Patch
Psychedelic biotech company PharmaTher says its ketamine patch could help relieve depression better than other treatments.
40 ‘New’ Psychedelic Compounds Found In More Than 25 Species of Mushrooms
Mydecine Innovations Group says it has found 40 new compounds in at least 25 types of mushrooms with psychedelic and potentially therapeutic properties.
Study Finds Synthetic Psilocybin Did Not Adversely Affect Cognitive Function
Is synthetic psilocybin as effective as the real thing? A new study looks at the risks and benefits of taking this lab-made psychedelic.
University of Calgary Creates Canada’s First Chair for Psychedelic Research
Canada gets its first chair for psychedelic research thanks to private citizen funding to the University of Calgary.
80 to 100% of Amputees Experience Phantom Limb Syndrome. Psilocybin May Help.
New research into psychedelics shows psilocybin may help amputees suffering from pain associated with phantom limb syndrome.
Psychedelic Business Spotlight: June 11, 2021
This week in psychedelic business news: An all-female biotech company, psychedelic-assisted psychotherapy for COVID front-liners, and more.
First-of-Its-Kind Genetic Psychedelic Test Kit Now Available In U.S.
The first genetic psychedelic test kit is now available in the U.S. The kits are designed to help users know how they’ll respond to psychedelics.
Seattle Council Tasks Drug Overdose Panel With Exploring Decriminalizing Psychedelics
Seattle city council members are being asked to review decriminalizing psychedelics.
